{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:23:55Z","timestamp":1780572235405,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clbc.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T11:46:12Z","timestamp":1599738372000},"page":"e141-e149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study"],"prefix":"10.1016","volume":"21","author":[{"given":"V.","family":"De Sanctis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Alf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vitiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Facondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Burocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Campanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Scalabrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Osti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"De Biase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.09.005_bib1","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2020.09.005_bib2","first-page":"11","article-title":"Historical trends of radiotherapy use in prevalent malignancies over 38 years in SEER","volume":"4","author":"Yeboa","year":"2015","journal-title":"J\u00a0Radiat Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(00)02263-7","article-title":"Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2020.09.005_bib4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.09.005_bib5","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1200\/JCO.2005.13.755","article-title":"Cardiac morbidity of adjuvant radiotherapy for breast cancer","volume":"23","author":"Patt","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/jnci\/dji067","article-title":"Risk of cardiac death after adjuvant radiotherapy for breast cancer","volume":"97","author":"Giordano","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2020.09.005_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijrobp.2014.06.030","article-title":"Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality","volume":"90","author":"Rutter","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.005_bib8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.breast.2010.03.003","article-title":"Hypofractionated breast radiotherapy: financial and economic consequences","volume":"19","author":"Lievens","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2020.09.005_bib9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.09.005_bib10","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.clbc.2017.08.011","article-title":"Trastuzumab and hypofractionated whole breast radiotherapy: a victorious combination?","volume":"18","author":"De Santis","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2020.09.005_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.18632\/oncotarget.6053","article-title":"Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab","volume":"7","author":"Cao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2020.09.005_bib12","first-page":"879","article-title":"Cardiotoxicity assessment after different adjuvant hypofractionated radiotherapy concurrently associated with trastuzumab in early breast cancer","volume":"32","author":"Bonzano","year":"2018","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.clbc.2020.09.005_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.lungcan.2008.03.024","article-title":"Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation","volume":"62","author":"Kozak","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.clbc.2020.09.005_bib14","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1007\/s13277-015-4183-7","article-title":"Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients","volume":"37","author":"De Iuliis","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clbc.2020.09.005_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000313528","article-title":"Effects of radiation therapy on myocardial cell integrity and pump function: which role for cardiac biomarkers?","volume":"56","author":"Nellessen","year":"2010","journal-title":"Chemotherapy"},{"key":"10.1016\/j.clbc.2020.09.005_bib16","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/j.ijrobp.2011.03.058","article-title":"N-terminal pro\u2013B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer","volume":"82","author":"D\u2019Errico","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.005_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tox.2007.12.006","article-title":"Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity","volume":"245","author":"O\u2019Brien","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.clbc.2020.09.005_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.4.3.457","article-title":"Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity","volume":"4","author":"Adamcova","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.clbc.2020.09.005_bib19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjcard.2006.10.052","article-title":"Mechanism of troponin elevations in patients with acute ischemic stroke","volume":"99","author":"Jensen","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clbc.2020.09.005_bib20","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ehj.2004.04.026","article-title":"Role and importance of biochemical markers in clinical cardiology","volume":"25","author":"Panteghini","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clbc.2020.09.005_bib21","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.09.022","article-title":"Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy","volume":"85","author":"Erven","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.005_bib22","first-page":"CD008966","article-title":"B-type natriuretic peptide\u2013guided treatment for heart failure","volume":"12","author":"McLellan","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clbc.2020.09.005_bib23","first-page":"3651","article-title":"Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors","volume":"25","author":"Perik","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2020.09.005_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.breast.2015.10.004","article-title":"Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients: a prospective study","volume":"25","author":"Palumbo","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2020.09.005_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.005_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.clbc.2020.09.005_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11883-017-0658-x","article-title":"Radiation-induced cardiovascular disease","volume":"19","author":"Raghunathan","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.clbc.2020.09.005_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1053-4296(03)00026-2","article-title":"Radiation-associated cardiovascular disease: manifestations and management","volume":"13","author":"Adams","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib29","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/bmj.298.6688.1611","article-title":"Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer","volume":"298","author":"Haybittle","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2020.09.005_bib30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.1994.12.3.447","article-title":"Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy","volume":"12","author":"Cuzick","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-8140(98)00062-0","article-title":"Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer","volume":"48","author":"Gyenes","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14737159.2017.1283219","article-title":"Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy","volume":"17","author":"Cardinale","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.clbc.2020.09.005_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-015-0436-2","article-title":"Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy","volume":"10","author":"Skytt\u00e4","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib34","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/JTO.0000000000000306","article-title":"Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure","volume":"9","author":"Gomez","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.clbc.2020.09.005_bib35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2018.11.013","article-title":"Early changes in cardiovascular biomarkers with contemporary thoracic radiation therapy for breast cancer, lung cancer, and lymphoma","volume":"103","author":"Demissei","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2020.09.005_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ijcard.2016.08.263","article-title":"Biomarkers of cardiac injury in patients undergoing thoracic radiation therapy","volume":"223","author":"Serrano","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clbc.2020.09.005_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14338\/IJPT-D-17-00022","article-title":"Evaluating cardiac biomarkers after chemotherapy and proton therapy for mediastinal Hodgkin lymphoma","volume":"4","author":"Guzhva","year":"2017","journal-title":"Int J Particle Ther"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:21:28Z","timestamp":1761513688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920302202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1526820920302202"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.09.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}